A new report, released today by the health arm of the National Academy of Sciences, says that few people are vitamin D deficient. The scientific research says otherwise.
You may have read that eating more omega-3 fatty acids doesn’t help heart patients. You absolutely will not believe what the researchers did to arrive at this result.
You saw the sensational media headlines last week: calcium supplements cause heart attacks! We told you the truth about this several weeks ago, before the latest research came out. If you take calcium, be sure to read this.
According to a major international study just published in the International Journal of Epidemiology “using a cell phone seems to protect against two types of brain tumor.” Let that sink in for just a moment and then learn that even the researchers behind the study, funded in part by the cell phone industry, did not believe their results. Which prompts many of us to ask the question “can we count on the studies, the gold standard of double-blind placebo controlled randomized clinical trials”?
Alliance for Natural Health-Intl recommends a scientifically defensible approach to establishing dosages for vitamin and mineral food-supplements.
The Natural Products Association (NPA) and the Council for Responsible Nutrition (CRN) have both voiced outrage over the publication of “Cancer Incidence and Mortality after Treatment with Folic Acid and Vitamin B12” in the 11/19/09 issue of JAMA.
Sen. Charles Grassley, R-Iowa, shines a spotlight on our nation’s medical schools and questions the practice of ghostwriting.
It’s silly, to tell the truth. Every so often, a major news outlet will publish an article to discourage people from taking vitamin supplements. The articles cite a by now familiar group of very badly designed and probably intentionally biased medical studies that are quoted because of their anti-supplement results. Sometimes the same old bogus […]
According to a British agricultural scientist, the key question is: “How can we make all of agriculture more sustainable?”
In 2007 a deal was struck between the British National Health Service (NHS) and drug manufacturer Johnson and Johnson (J&J). NHS had decided not to pay for J&J’s cancer drug, Velcade, so J&J gave NHS a money-back guarantee.